Evidence-based recommendations for the prevention and long-term management of thrombosis in antiphospholipid antibody-positive patients: report of a task Force at the 13th International Congress on antiphospholipid antibodies

International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)

MIYAKIS, S., LOCKSHIN, M. D., ATSUMI, T., BRANCH, D. W., BREY, R. L., CERVERA, R., DERKSEN, R. H. W. M., DE GROOT, P. G., KOIKE, T., MERONI, P. L., et al. (2006) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2006.01753.x · Cited by 7,203 · see citing works

Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients

Cervera, R., Piette, J., Font, J., Khamashta, M. A., Shoenfeld, Y., Camps, M. T., Jacobsen, S., Lakos, G., Tincani, A., Kontopoulou‐Griva, I., et al. (2002) · Arthritis & Rheumatism · doi:10.1002/art.10187 · Cited by 2,156 · see citing works

Antithrombotic Therapy for Venous Thromboembolic Disease

Kearon, C., Kahn, S. R., Agnelli, G., Goldhaber, S. Z., Raskob, G. E., & Comerota, A. J. (2008) · CHEST Journal · doi:10.1378/chest.08-0658 · Cited by 1,983 · see citing works

Age-specific Incidence Rates of Myocardial Infarction and Angina in Women with Systemic Lupus Erythematosus: Comparison with the Framingham Study

Manzi, S., Meilahn, E. N., Rairie, J. E., Conte, C. G., Medsger, T. A., Jansen-McWilliams, L., D’Agostino, R. B., & Kuller, L. H. (1997) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a009122 · Cited by 1,831 · see citing works

The management of thrombosis in the antiphospholipid-antibody syndrome

Khamashta, M. A., Cuadrado, M. J., Mujic, F., Taub, N. A., Hunt, B. J., & Hughes, G. R. V. (1995) · New England Journal of Medicine · doi:10.1056/nejm199504133321504 · Cited by 1,450 · see citing works

Clinical efficacy and side effects of antimalarials in systemic lupus erythematosus: a systematic review

Ruiz-Irastorza, G., Ramos-Casals, M., Brito-Zeron, P., & Khamashta, M. A. (2010) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2008.101766 · Cited by 978 · see citing works

Lupus anticoagulants are stronger risk factors for thrombosis than anticardiolipin antibodies in the antiphospholipid syndrome: a systematic review of the literature

Galli, M., Luciani, D., Bertolini, G., & Barbui, T. (2003) · Blood · doi:10.1182/blood-2002-02-0441 · Cited by 974 · see citing works

Morbidity and mortality in the antiphospholipid syndrome during a 10-year period: a multicentre prospective study of 1000 patients

Cervera, R., Serrano, R., Pons-Estel, G. J., Ceberio-Hualde, L., Shoenfeld, Y., de Ramón, E., Buonaiuto, V, Jacobsen, S., Zeher, M. M., Tarr, T., et al. (2015) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2013-204838 · Cited by 974 · see citing works

A comparison of two intensities of warfarin for the prevention of recurrent thrombosis in patients with the antiphospholipid antibody syndrome

Crowther, M. A., Ginsberg, J. S., Julian, J., Denburg, J., Hirsh, J., Douketis, J., Laskin, C., Fortin, P., Anderson, D., Kearon, C., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa035241 · Cited by 919 · see citing works

Antiphospholipid syndrome

Ruiz‐Irastorza, G., Crowther, M. A., Branch, W. D., & Khamashta, M. A. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60709-x · Cited by 864 · see citing works

Risk of bleeding with single, dual, or triple therapy with warfarin, aspirin, and clopidogrel in patients with atrial fibrillation

Hansen, M. L., Sørensen, R., Clausen, M. T., Fog-Petersen, M. L., Raunsø, J., Gadsbøll, N., Gislason, G. H., Folke, F., Andersen, S. S., Schramm, T. K., et al. (2010) · Archives of Internal Medicine · doi:10.1001/archinternmed.2010.271 · Cited by 855 · see citing works

Antiplatelet Drugs

Patrono, C., Baigent, C., Hirsh, J., & Roth, G. J. (2008) · CHEST Journal · doi:10.1378/chest.08-0672 · Cited by 749 · see citing works

A Randomized Trial of Rosuvastatin in the Prevention of Venous Thromboembolism

Glynn, R. J., Danielson, E., Fonseca, F. A. H., Genest, J. J., Gotto, A. M., Kastelein, J. J. P., Köenig, W., Libby, P., Lorenzatti, A. J., MacFadyen, J. G., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0900241 · Cited by 748 · see citing works

Hemorrhagic Complications of Anticoagulant and Thrombolytic Treatment

Schulman, S., Beyth, R. J., Kearon, C., & Levine, M. N. (2008) · CHEST Journal · doi:10.1378/chest.08-0674 · Cited by 737 · see citing works

Clinical course of high‐risk patients diagnosed with antiphospholipid syndrome

PENGO, V., RUFFATTI, A., LEGNANI, C., GRESELE, P., BARCELLONA, D., ERBA, N., TESTA, S., MARONGIU, F., BISON, E., DENAS, G., et al. (2010) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2009.03674.x · Cited by 633 · see citing works

A randomized clinical trial of high‐intensity warfarin vs. conventional antithrombotic therapy for the prevention of recurrent thrombosis in patients with the antiphospholipid syndrome (WAPS)

FINAZZI, G., MARCHIOLI, R., BRANCACCIO, V., SCHINCO, P., WISLOFF, F., MUSIAL, J., BAUDO, F., BERRETTINI, M., Testa, S., D'ANGELO, A., et al. (2005) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2005.01340.x · Cited by 585 · see citing works

Anticardiolipin Antibodies Predict Early Recurrence of Thromboembolism and Death Among Patients with Venous Thromboembolism Following Anticoagulant Therapy

Schulman, S., Svenungsson, E., & Granqvist, S. (1998) · The American Journal of Medicine · doi:10.1016/s0002-9343(98)00060-6 · Cited by 497 · see citing works

Classification of Stroke Subtypes

Amarenco, P., Bogousslavsky, J., Caplan, L. R., Donnan, G. A., & Hennerici, M. G. (2009) · Cerebrovascular Diseases · doi:10.1159/000210432 · Cited by 475 · see citing works

A Computerized Algorithm for Etiologic Classification of Ischemic Stroke

Ay, H., Benner, T., Arsava, E. M., Furie, K. L., Singhal, A. B., Jensen, M., Ayata, C., Towfighi, A., Smith, E. E., Chong, J. Y., et al. (2007) · Stroke · doi:10.1161/strokeaha.107.490896 · Cited by 455 · see citing works

Management of Antiphospholipid Antibody Syndrome

Lim, W., Crowther, M. A., & Eikelboom, J. W. (2006) · JAMA · doi:10.1001/jama.295.9.1050 · Cited by 440 · see citing works

Morbidity and Mortality in Systemic Lupus Erythematosus During a 5-Year Period: A Multicenter Prospective Study of 1,000 Patients

Cervera, R., Khamashta, M. A., Font, J., Sebastiani, G. D., Gil, A., Lavilla, P., Aydintug, A., Jędryka-Góral, A., de Ramón, E., Fernández‐Nebro, A., et al. (1999) · Medicine · doi:10.1097/00005792-199905000-00003 · Cited by 429 · see citing works

Antiphospholipid antibodies and risk of myocardial infarction and ischaemic stroke in young women in the RATIO study: a case-control study

Urbanus, R. T., Siegerink, B., Roest, M., Rosendaal, F. R., de Groot, P. G., & Algra, A. (2009) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70239-x · Cited by 429 · see citing works

Natural history and risk factors for thrombosis in 360 patients with antiphospholipid antibodies: a four‐year prospective study from the Italian Registry

Finazzi, G., Brancaccio, V., Moia, M., Ciavarella, N., Mazzucconi, M. G., Schinco, P., Ruggeri, M., Pogliani, E. M., Gamba, G., Rossi, E., et al. (1996) · The American Journal of Medicine · doi:10.1016/s0002-9343(96)00060-5 · Cited by 427 · see citing works

Anti–β2-glycoprotein I, antiprothrombin antibodies, and the risk of thrombosis in the antiphospholipid syndrome

Galli, M., Luciani, D., Bertolini, G., & Barbui, T. (2003) · Blood · doi:10.1182/blood-2002-11-3334 · Cited by 413 · see citing works

Aspirin for primary thrombosis prevention in the antiphospholipid syndrome: a randomized, double-blind, placebo controlled trial in asymptomatic antiphospholipid antibody-positive individuals.

Erkan, D., Harrison, M. J., Levy, R., Peterson, M., Petri, M., Sammaritano, L., Unalp‐Arida, A., Vilela, V., Yazici, Y., & Lockshin, M. D. (2007) · Arthritis & Rheumatism · doi:10.1002/art.22663 · Cited by 401 · see citing works

Risk factors for thrombosis and primary thrombosis prevention in patients with systemic lupus erythematosus with or without antiphospholipid antibodies

Tektonidou, M. G., Laskari, K., Panagiotakos, D. B., & Moutsopoulos, H. M. (2009) · Arthritis Care & Research · doi:10.1002/art.24232 · Cited by 356 · see citing works

A cross-sectional study of clinical thrombotic risk factors and preventive treatments in antiphospholipid syndrome

Erkan, D. (2002) · Rheumatology · doi:10.1093/rheumatology/41.8.924 · Cited by 330 · see citing works

A systematic review of secondary thromboprophylaxis in patients with antiphospholipid antibodies

Ruiz‐Irastorza, G., Hunt, B. J., & Khamashta, M. A. (2007) · Arthritis Care & Research · doi:10.1002/art.23109 · Cited by 324 · see citing works

Antibody profiles for the diagnosis of antiphospholipid syndrome

Biasiolo, A., Pegoraro, C., Cucchini, U., Noventa, F., Iliceto, S., & Pengo, V. (2005) · Thrombosis and Haemostasis · doi:10.1160/th04-12-0839 · Cited by 318 · see citing works

Antithrombotic and Thrombolytic Therapy for Ischemic Stroke

Albers, G. W., Amarenco, P., Easton, J. D., Sacco, R. L., & Teal, P. A. (2008) · CHEST Journal · doi:10.1378/chest.08-0720 · Cited by 318 · see citing works

Major bleeding during anticoagulation after cerebral ischemia

Gorter, J. W., (SPIRIT), F. T. S. P. I. R. I. T., & Groups, E. A. F. T. (. S. (1999) · Neurology · doi:10.1212/wnl.53.6.1319 · Cited by 311 · see citing works

The protective effect of antimalarial drugs on thrombovascular events in systemic lupus erythematosus

Jung, H., Bobba, R., Su, J., Shariati‐Sarabi, Z., Gladman, D. D., Urowitz, M., Lou, W., & Fortin, P. R. (2010) · Arthritis & Rheumatism · doi:10.1002/art.27289 · Cited by 291 · see citing works

The association between circulating antibodies against domain I of beta2‐glycoprotein I and thrombosis: an international multicenter study

DE LAAT, B., PENGO, V., PABINGER, I., MUSIAL, J., VOSKUYL, A. E., BULTINK, I. E. M., RUFFATTI, A., ROZMAN, B., KVEDER, T., DE MOERLOOSE, P., et al. (2009) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2009.03588.x · Cited by 291 · see citing works

Morbidity and mortality in the antiphospholipid syndrome during a 5-year period: a multicentre prospective study of 1000 patients

Cervera, R., Khamashta, M. A., Shoenfeld, Y., Camps, M. T., Jacobsen, S., Kiss, E., Zeher, M. M., Tincani, A., Kontopoulou-Griva, I., Galeazzi, M., et al. (2009) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2008.093179 · Cited by 286 · see citing works

Systematic Review: d -Dimer to Predict Recurrent Disease after Stopping Anticoagulant Therapy for Unprovoked Venous Thromboembolism

Verhovsek, M. M., Douketis, J. D., Yi, Q., Shrivastava, S., Tait, R. C., Baglin, T. P., Poli, D., & Lim, W. (2008) · Annals of Internal Medicine · doi:10.7326/0003-4819-149-7-200810070-00008 · Cited by 268 · see citing works

Untitled work

(2006) · PubMed · Cited by 248 · see citing works

Risk and protective factors for thrombosis in systemic lupus erythematosus: results from a large, multi-ethnic cohort

Kaiser, R., Cleveland, C. M., & Criswell, L. A. (2009) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2008.093013 · Cited by 244 · see citing works

High Impact of Antiphospholipid Syndrome on Irreversible Organ Damage and Survival of Patients With Systemic Lupus Erythematosus

Ruiz‐Irastorza, G., Egurbide, M.-V., Ugalde, J., & Aguirre, C. (2004) · Archives of Internal Medicine · doi:10.1001/archinte.164.1.77 · Cited by 238 · see citing works

Incidence and risk factors of thromboembolism in systemic lupus erythematosus: A comparison of three ethnic groups

Mok, C. C., Tang, S. S. K., To, C. H., & Petri, M. (2005) · Arthritis & Rheumatism · doi:10.1002/art.21224 · Cited by 237 · see citing works

Dermatologic manifestations of the antiphospholipid syndrome: Two hundred consecutive cases

Francès, C., Niang, S. O., Laffitte, E., Pelletier, F. L., Costedoat-Chalumeau, N., & Piette, J. C. (2005) · Arthritis & Rheumatism · doi:10.1002/art.21041 · Cited by 229 · see citing works

Untitled work

(2004) · PubMed · Cited by 218 · see citing works

Current concepts on the pathogenesis of the antiphospholipid syndrome

Giannakopoulos, B., Passam, F. H., Rahgozar, S., & Krilis, S. A. (2006) · Blood · doi:10.1182/blood-2006-04-001206 · Cited by 217 · see citing works

Outcome of patients with anticardiolipin antibodies: a 10 year follow-up of 52 patients

Shah, N. M., Khamashta, M. A., Atsumi, T., & Hughes, G. R. (1998) · Lupus · doi:10.1191/096120398678919624 · Cited by 204 · see citing works

Residual vein thrombosis to establish duration of anticoagulation after a first episode of deep vein thrombosis: the Duration of Anticoagulation based on Compression UltraSonography (DACUS) study

Siragusa, S. M., Malato, A., Anastasio, R., Cigna, V., Milio, G., Amato, C., Bellisi, M. G., Attanzio, M. T., Cormaci, O., Pellegrino, M., et al. (2008) · Blood · doi:10.1182/blood-2008-01-131656 · Cited by 193 · see citing works

Determinants of risk for venous and arterial thrombosis in primary antiphospholipid syndrome and in antiphospholipid syndrome with systemic lupus erythematosus

DANOWSKI, A., de AZEVEDO, M. N. L., de SOUZA PAPI, J. A., & PETRI, M. (2009) · The Journal of Rheumatology · doi:10.3899/jrheum.081194 · Cited by 192 · see citing works

Grades of Recommendation for Antithrombotic Agents

Guyatt, G. H., Cook, D. J., Jaeschke, R., Pauker, S. G., & Schünemann, H. J. (2008) · CHEST Journal · doi:10.1378/chest.08-0654 · Cited by 186 · see citing works

How we diagnose the antiphospholipid syndrome

Giannakopoulos, B., Passam, F. H., Ioannou, Y., & Krilis, S. A. (2008) · Blood · doi:10.1182/blood-2007-12-129627 · Cited by 186 · see citing works

A prospective study of antibodies to β2‐glycoprotein I and prothrombin, and risk of thrombosis

FORASTIERO, R., MARTINUZZO, M., POMBO, G., PUENTE, D., ROSSI, A., CELEBRIN, L., BONACCORSO, S., & AVERSA, L. (2005) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2005.01295.x · Cited by 170 · see citing works

Antibody profile and clinical course in primary antiphospholipid syndrome with pregnancy morbidity

Ruffatti, A., Tonello, M., Del Ross, T., Cavazzana, A., Grava, C., Noventa, F., Tona, F., Iliceto, S., & Pengo, V. (2006) · Thrombosis and Haemostasis · doi:10.1160/th06-05-0287 · Cited by 170 · see citing works

Clinical significance of different antiphospholipid antibodies in the WAPS (warfarin in the antiphospholipid syndrome) study

Galli, M., Borrelli, G., Jacobsen, E. M., Marfisi, R. M., Finazzi, G., Marchioli, R., Wisloff, F., Marziali, S., Morboeuf, O., & Barbui, T. (2007) · Blood · doi:10.1182/blood-2007-01-066043 · Cited by 170 · see citing works

Diagnostic Testing for Coagulopathies in Patients With Ischemic Stroke

Bushnell, C., & Goldstein, L. B. (2000) · Stroke · doi:10.1161/01.str.31.12.3067 · Cited by 165 · see citing works

Prophylactic Antithrombotic Therapy for Patients With Systemic Lupus Erythematosus With or Without Antiphospholipid Antibodies

Wahl, D. G., Bounameaux, H., de Moerloose, P., & Sarasin, F. (2000) · Archives of Internal Medicine · doi:10.1001/archinte.160.13.2042 · Cited by 155 · see citing works

Cardiac disease in the antiphospholipid syndrome: recommendations for treatment. Committee consensus report

Lockshin, M. D., Tenedios, F., Petri, M., McCarty, G. A., Forastiero, R. R., Krilis, S. A., Tincani, A., Erkan, D., Khamashta, M. A., & Shoenfeld, Y. (2003) · Lupus · doi:10.1191/0961203303lu391oa · Cited by 129 · see citing works

Untitled work

(1994) · PubMed · Cited by 116 · see citing works

Risk factors for a first thrombotic event in antiphospholipid antibody carriers. A multicentre, retrospective follow-up study

Ruffatti, A., Ross, T. D., Ciprian, M., Nuzzo, M., Rampudda, M., Bertero, M. T., Bergia, R., Caramaschi, P., Biasi, D., Capsoni, F., et al. (2009) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2008.096669 · Cited by 106 · see citing works

Comparison between single antiplatelet therapy and combination of antiplatelet and anticoagulation therapy for secondary prevention in ischemic stroke patients with antiphospholipid syndrome

Okuma, H., Kitagawa, Y., Yasuda, T., Tokuoka, K., & Takagi, S. (2010) · International Journal of Medical Sciences · doi:10.7150/ijms.7.15 · Cited by 102 · see citing works

Analysis of risk factors for the development of thrombotic complications in antiphospholipid antibody positive lupus patients

Tarr, T., Lakos, G., Bhattoa, H. P., Shoenfeld, Y., Szegedi, G., & Kiss, E. (2007) · Lupus · doi:10.1177/0961203306074767 · Cited by 88 · see citing works

Influence of aspirin on the clinical outcomes of 103 anti-phospholipid antibodies-positive patients

Hereng, T., Lambert, M., HACHULLA, E., Samor, M., Dubucquoi, S., Caron, C., Launay, D., Morell‐Dubois, S., Queyrel, V., & Hatron, P. (2007) · Lupus · doi:10.1177/0961203307084724 · Cited by 84 · see citing works

Recurrent miscarriage and long-term thrombosis risk: a case–control study

Quenby, S. M., Farquharson, R. G., Dawood, F. A., Hughes, A. M., & Topping, J. (2005) · Human Reproduction · doi:10.1093/humrep/deh844 · Cited by 84 · see citing works

How I treat the antiphospholipid syndrome

Giannakopoulos, B., & Krilis, S. A. (2009) · Blood · doi:10.1182/blood-2009-05-220756 · Cited by 83 · see citing works

Thrombophilia testing in patients with venous thromboembolism. Findings from the RIETE registry

Roldán, V., Lecumberri, R., Muñoz-Torrero, J. F. S., et al. (2008) · Thrombosis Research · doi:10.1016/j.thromres.2008.11.003 · Cited by 81 · see citing works

Prognostic factors and clustering of serious clinical outcomes in antiphospholipid syndrome

Tektonidou, M. G. (2000) · QJM · doi:10.1093/qjmed/93.8.523 · Cited by 80 · see citing works

Transiently positive anticardiolipin antibodies and risk of thrombosis in patients with systemic lupus erythematosus

Martinez-Berriotxoa, A., Ruiz-Irastorza, G., Egurbide, M.-V., Garmendia, M., Gabriel Erdozain, J., Villar, I., & Aguirre, C. (2007) · Lupus · doi:10.1177/0961203307083316 · Cited by 77 · see citing works

Antiphospholipid antibody profiles and their clinical associations in Chinese patients with systemic lupus erythematosus.

Mok, M. Y., Chan, E. Y. T., Fong, D., Leung, K. F. S., Wong, W. S., & Lau, C. S. (2005) · PubMed · Cited by 74 · see citing works

Statins for the Treatment of Antiphospholipid Syndrome?

Jajoria, P., Murthy, V. L., Papalardo, E., Romay‐Penabad, Z., Gleason, C. E., & Pierangeli, S. S. (2009) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.04815.x · Cited by 55 · see citing works

Long‐duration therapy with low molecular weight heparin in patients with antiphospholipid antibody syndrome resistant to warfarin therapy

Dentali, F., Manfredi, E., Crowther, M. A., & Ageno, W. (2005) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2005.01516.x · Cited by 44 · see citing works

Do antiphospholipid antibodies increase the long-term risk of thrombotic complications in young patients with a recent TIA or ischemic stroke?

van Goor, M. P. J., Alblas, C. L., Leebeek, F. W. G., Koudstaal, P. J., & Dippel, D. W. J. (2004) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.2004.00241.x · Cited by 42 · see citing works

Retirada de la anticoagulación en el síndrome antifosfolípido primario cuando se negativizan los anticuerpos anticardiolipina

Criado-García, J., Fernandez‐Puebla, R. A., Jiménez, L. L., et al. (2008) · Revista Clínica Española · doi:10.1157/13115821 · Cited by 41 · see citing works

Risky business: the interpretation, use, and abuse of antiphospholipid antibody tests in clinical practice

Roubey, R. (2010) · Lupus · doi:10.1177/0961203310361356 · Cited by 39 · see citing works

Patent Foramen Ovale, Cardiac Valve Thickening, and Antiphospholipid Antibodies as Risk Factors for Subsequent Vascular Events

Rajamani, K., Chaturvedi, S., Jin, Z., Homma, S., Brey, R. L., Tilley, B. C., Sacco, R. L., Thompson, J. L. P., Mohr, J. P., & Levine, S. R. (2009) · Stroke · doi:10.1161/strokeaha.108.539171 · Cited by 34 · see citing works

Antiphospholipid antibodies predict imminent vascular events independently from other risk factors in a prospective cohort.

Neville, C., Rauch, J., Kassis, J., et al. (2009) · PubMed · Cited by 32 · see citing works

Antiphospholipid antibodies predict imminent vascular events independently from other risk factors in a prospective cohort

Kassis, J., Solymoss, S., Joseph, L., Bélisle, P., Levine, J. S., Neville, C., Rauch, J., & Fortin, P. R. (2008) · Thrombosis and Haemostasis · doi:10.1160/th08-06-0384 · Cited by 31 · see citing works

Clinical manifestations and outcomes of antithrombotic treatment of the Tan Tock Seng Hospital Singapore antiphospholipid syndrome cohort

Be, T., Thong, B. Y., Shivananda, S., et al. (2009) · Lupus · doi:10.1177/0961203309103303 · Cited by 24 · see citing works

Factores relacionados con el riesgo de trombosis en pacientes con lupus y positividad para anticuerpos antifosfolipídicos

Martínez, F., Forner, M. J., Ruano, M., et al. (2006) · Medicina Clínica · doi:10.1157/13092765 · Cited by 12 · see citing works

Specific presence of intracellular citrullinated proteins in rheumatoid arthritis synovium: relevance to antifilaggrin autoantibodies

Ho (2001) · Pure Amsterdam UMC · doi:10.1002/1529-0131(200110)44:10 · Cited by 3 · see citing works

Untitled work

Pope (2001) · doi:10.1002/1529-0131(200106)44:6

Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association

Kernan, W. N., Ovbiagele, B., Black, H. R., Bravata, D. M., Chimowitz, M. I., Ezekowitz, M. D., Fang, M. C., Fisher, M., Furie, K. L., Heck, D. V., et al. (2014) · Stroke · doi:10.1161/str.0000000000000024 · Cited by 5,170 · see citing works

EULAR recommendations for the management of antiphospholipid syndrome in adults

Tektonidou, M. G., Andreoli, L., Limper, M., Amoura, Z., Cervera, R., Costedoat-Chalumeau, N., Cuadrado, M. J., Dörner, T., Ferrer-Oliveras, R., Hambly, K., et al. (2019) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2019-215213 · Cited by 1,261 · see citing works

GAPSS: the Global Anti-Phospholipid Syndrome Score

Sciascia, S., Sanna, G., Murru, V., Roccatello, D., Khamashta, M. A., & Bertolaccini, M. L. (2013) · Rheumatology · doi:10.1093/rheumatology/kes388 · Cited by 318 · see citing works

Efficacy of aspirin for the primary prevention of thrombosis in patients with antiphospholipid antibodies: an international and collaborative meta-analysis

Arnaud, L., Mathian, A., Ruffatti, A., Erkan, D., Tektonidou, M., Cervera, R., Forastiero, R., Pengo, V., Lambert, M., Martinez-Zamora, M. A., et al. (2014) · Autoimmunity Reviews · doi:10.1016/j.autrev.2013.10.014 · Cited by 215 · see citing works

Risk of venous and arterial thrombosis according to type of antiphospholipid antibodies in adults without systemic lupus erythematosus: a systematic review and meta-analysis

Reynaud, Q., Lega, J.-C., Mismetti, P., Chapelle, C., Wahl, D., Cathébras, P., & Laporte, S. (2014) · Autoimmunity Reviews · doi:10.1016/j.autrev.2013.11.004 · Cited by 179 · see citing works

Patient-level analysis of five international cohorts further confirms the efficacy of aspirin for the primary prevention of thrombosis in patients with antiphospholipid antibodies

Arnaud, L., Mathian, A., Devilliers, H., Ruffatti, A., Tektonidou, M., Forastiero, R., Pengo, V., Lambert, M., Lefevre, G., Martinez-Zamora, M. A., et al. (2015) · Autoimmunity Reviews · doi:10.1016/j.autrev.2014.10.019 · Cited by 146 · see citing works

Long-term use of hydroxychloroquine reduces antiphospholipid antibodies levels in patients with primary antiphospholipid syndrome

Nuri, E., Taraborelli, M., Andreoli, L., Tonello, M., Gerosa, M., Calligaro, A., Argolini, L. M., Kumar, R., Pengo, V., Meroni, P. L., et al. (2017) · Immunologic Research · doi:10.1007/s12026-016-8812-z · Cited by 124 · see citing works

The effect of hydroxychloroquine on thrombosis prevention and antiphospholipid antibody levels in primary antiphospholipid syndrome: A pilot open label randomized prospective study

Kravvariti, E., Koutsogianni, A., Samoli, E., Sfikakis, P. P., & Tektonidou, M. G. (2020) · Autoimmunity Reviews · doi:10.1016/j.autrev.2020.102491 · Cited by 112 · see citing works

Persistent triple antiphospholipid antibody positivity as a strong risk factor of first thrombosis, in a long‐term follow‐up study of patients without history of thrombosis or obstetrical morbidity

Yelnik, C. M., Urbanski, G., Drumez, E., Sobanski, V, Maillard, H., Lanteri, A., Morell-Dubois, S., Caron, C., Dubucquoi, S., Launay, D., et al. (2017) · Lupus · doi:10.1177/0961203316657433 · Cited by 73 · see citing works

Patients with antiphosholipid syndrome and thrombotic recurrences: A real world observation (the Piedmont cohort study)

Bazzan, M., Vaccarino, A., Stella, S., Sciascia, S., Montaruli, B., Bertero, M. T., Carignola, R., Roccatello, D., & for the Piedmont APS Consortium (2016) · Lupus · doi:10.1177/0961203315617538 · Cited by 56 · see citing works

Pregnancy outcome in patients with antiphospholipid syndrome after cerebral ischaemic events: an observational study

Fischer-Betz, R., Specker, C., Brinks, R., & Schneider, M. (2012) · Lupus · doi:10.1177/0961203312451335 · Cited by 56 · see citing works

Antiphospholipid Antibodies and Recurrent Thrombotic Events: Persistence and Portfolio

Amory, C. F., Levine, S. R., Brey, R. L., Gebregziabher, M., Tuhrim, S., Tilley, B. C., Simpson, A.-C. C., Sacco, R. L., Mohr, J. P., & Collaborators, F. T. A.-W. (2015) · Cerebrovascular Diseases · doi:10.1159/000441362 · Cited by 31 · see citing works

P48 Anti-beta 2-glycoprotein as compared with anticardiolipin antibody and lupus anticoagulant in diagnosis of antiphospholipid antibody syndrome

Sandhya, P., Prakash, J., Saritha, E., et al. (2008) · Indian Journal of Rheumatology · doi:10.1016/s0973-3698(10)60492-x

Prevalence of Anticardiolipin Antibodies in Pregnancies with History of Repeated Miscarriages

Spegiorin, L. C. J. F., Galão, E. A., Bagarelli, L. B., et al. (2010) · The Open Rheumatology Journal · doi:10.2174/1874312901004010028 · Cited by 12 · see citing works

Laboratory testing for antiphospholipid syndrome

Pengo, V., Banzato, A., Bison, E., Denas, G., Zoppellaro, G., Bracco, A., Jose, S. P., Hoxha, A., & Ruffatti, A. (2016) · International Journal of Laboratory Hematology · doi:10.1111/ijlh.12507 · Cited by 29 · see citing works

The clinical associations of lupus anticoagulant and anticardiolipin antibodies.

Chogle, A. R., & Buchanan, R. R. C. (1994) · PubMed